PRLH and obesity due to melanocortin 4 receptor deficiency: The rapid systemic clearance of GUB02647 and GUB03385 makes it conceivable that the anti-obesity efficacy of these PrRP analogues is not ascribed to the parent peptide, but rather determined by potent bioactive metabolite(s) with retained lipidation and high plasma stability.